Showing 12 out of 95 results
Near enough is good enough: Full Federal Court of Australia revisits construction of “about” in patent claim
In the area of patent law, clarity is king. Where precision of language is essential for defining the limits and scope of legal rights, the acceptance …
Penalties for breaches of Australian competition and consumer law set to increase
On 18 August 2022, the Commonwealth Government released draft legislation proposing five-fold increases in the maximum penalties that apply to companies …
First things first: Full Federal Court clarifies the law on patent term extensions
Last week, a Full Court of the Federal Court of Australia handed down two unanimous decisions on appeal, clearing up some key uncertainties in the …
Climate change: succeed in a net-zero future
The risks associated with climate change go way beyond the purely environmental.In our climate change briefing we consider at a high level the political, …
Herbert Smith Freehills advises IFM on sale of Genie Solutions to Pacific Equity Partners’ owned Citadel
Herbert Smith Freehills has advised IFM Investors’ private equity arm on the sale of its majority owned medical practice management software business, …
FEDERAL COURT OVERTURNS ‘ABSURD’ PATENT OFFICE RULING ON PATENT TERM EXTENSIONS FOR PHARMACEUTICAL SUBSTANCES
The Federal Court has rejected the Australian Patent Office’s historical approach to patent term extension (PTE) applications, upholding a challenge …
Pharmaceutical patent term extensions: federal court hears challenge to “absurd” Australian patent office ruling
Two major pharmaceutical companies have challenged Australia’s Commissioner of Patents in the Federal Court about the time limits within which an …
Herbert Smith Freehills advises Rosemary Health on Series Seed-2 capital raise
Herbert Smith Freehills’ Venture Capital team has advised Rosemary Health on its Series Seed-2 capital raise.Rosemary Health is a telehealth platform …
2021 M&A predictions hold up in first quarter, but challenges remain
Predictions for an active year for Asia Pacific M&A in a new report from global law firm Herbert Smith Freehills are holding up in the first quarter, …
A ‘new normal’ when it comes to the TGA regulation of medical devices?
Key points: In Australia responding to the urgent need for Covid-related medical devices the TGA implemented a number of emergency measures to bring …
Asia Pacific M&A Review 2021
Our eighth annual review of Asia's deal scene assesses the outlook for big-ticket M&A after a turbulent but eventful yearChange is the only constant …
2020 Australian IPO Review: Key themes
2020 in review Market conditions in 2020 were of course impacted by the Covid-19 pandemic, but also by record low interest …
Showing 12 out of 95 results
View more